Viking Therapeutics, Inc. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee first SUPPLEMENTAL INDENTURE Dated as of September 25, 2026 2.00% Convertible Senior Notes due 2032